Return to Statistics Toolbox

Correlation analysis for Study ST002024

Nodes mapped to fold-change between 2 conditions

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:20190304-Blank (5)
Treatment:20190304-LipL2_AP_acetate (3)
Treatment:20190304-LipL2_AP_glucose (3)
Treatment:20190304-LipL2_AP_glutamine (3)
Treatment:20190304-QC (3)
Treatment:20190304-WT_AP_acetate (3)
Treatment:20190304-WT_AP_glucose (3)
Treatment:20190304-WT_AP_glutamine (3)
Treatment:20190313-Blank (5)
Treatment:20190313-LipL2_acetate (3)
Treatment:20190313-LipL2_glucose (3)
Treatment:20190313-LipL2_glutamine (3)
Treatment:20190313-QC (3)
Treatment:20190313-WT_acetate (3)
Treatment:20190313-WT_glucose (3)
Treatment:20190313-WT_glutamine (3)
Treatment:20190401-Blank (5)
Treatment:20190401-LipL2-glucose (3)
Treatment:20190401-LipL2-glutamine (3)
Treatment:20190401-QC (3)
Treatment:20190401-WT-glucose (3)
Treatment:20190401-WT-glutamine (3)
Treatment:20191107-BKE2_glucose (3)
Treatment:20191107-BKE2_glutamine (3)
Treatment:20191107-Blank (5)
Treatment:20191107-QC (3)
Treatment:20191107-WT_glucose (3)
Treatment:20191107-WT_glutamine (3)
Treatment:20191120-BKE2_glucose (3)
Treatment:20191120-BKE2_glutamine (3)
Treatment:20191120-Blank (5)
Treatment:20191120-QC (3)
Treatment:20191216-Blank (5)
Treatment:20191216-LipL2-glucose (3)
Treatment:20191216-LipL2-glutamine (3)
Treatment:20191216-QC (3)
Treatment:20191216-WT-glucose (3)
Treatment:20191216-WT-glutamine (3)
Treatment:20200810-BE12-Glucose-B1 (3)
Treatment:20200810-BE12-Glucose-B2 (3)
Treatment:20200810-BE12-Glutamine-B1 (3)
Treatment:20200810-BE12-Glutamine-B2 (3)
Treatment:20200810-Blank (5)
Treatment:20200810-QC (3)
Analysis:  Combine data for all analyses?:

  logo